Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 213 JPY 0.29% Market Closed
Market Cap: 6.7T JPY
Have any thoughts about
Takeda Pharmaceutical Co Ltd?
Write Note

Gross Margin
Takeda Pharmaceutical Co Ltd

66.2%
Current
68%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.2%
=
Gross Profit
2.9T
/
Revenue
4.4T

Gross Margin Across Competitors

Country JP
Market Cap 6.6T JPY
Gross Margin
66%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 746.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 365.6B USD
Gross Margin
69%
Country US
Market Cap 249.1B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Takeda Pharmaceutical Co Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
66.2%
=
Gross Profit
2.9T
/
Revenue
4.4T
What is the Gross Margin of Takeda Pharmaceutical Co Ltd?

Based on Takeda Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 66.2%.